Literature DB >> 179934

Histochemistry, ultrastructure and hormone content of human insulinomas.

W Creutzfeldt, C Creutzfeldt, H Frerichs, N S Track, R Arnold.   

Abstract

Forty human insulin-producing tumors were investigated with histochemical, immunohistological and ultrastructural methods and extracted for insulin and proinsulin. These studies resulted in the following findings: 1) A variable number of tumor cells contained only a few or often no beta granules. 2) The insulin concentration was lower and the proinsulin percentage higher in insulinoma cells compared with normal beta-cells. 3) According to the ultrastructural appearance of the secretory granules four types of insulinoma were established. 4) Insulinomas frequently contained cells with atypical secretory granules which were Grimelius silver-positive. Their similarity to the Type IV islet cell and to cells regularly found in gastrinomas, Verner-Morrison tumors and glucagonomas suggests that all endocrine pancreatic tumors originate from a common precursor cell. 5) The morphological and biochemical findings support the theory that uncontrolled hormone release and/or decreased storage capacity are responsible for fasting hyperinsulinism in insulinoma patients. 6) The severity of hypoglycemia symptoms and the result of stimulatory tests were not related to the size, the insulin concentration and the total insulin content of the tumor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179934

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

1.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

2.  Growth hormone and metasomatotrophic diabetes: effects on insulin and proinsulin of serum and pancreas in dogs.

Authors:  J Pierluissi; J Campbell
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

3.  Histochemical, clinical, and in vitro beta cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy.

Authors:  N S Panesar; C W Poon; C T Liew; G W Wong; N M Hjelm
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

4.  [Diagnosis and surgery of an insulinoma using a glucose-controlled insulin infusion system].

Authors:  G Müller-Esch; A Valesky; U Weber; G Wood
Journal:  Klin Wochenschr       Date:  1984-01-16

5.  Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.

Authors:  Belén Pérez-Pevida; Miguel Ángel Idoate; Sara Fernández-Landázuri; Nerea Varo; Javier Escalada
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

6.  The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.

Authors:  Jean-Marc Guettier; Andreea Lungu; Anne Goodling; Craig Cochran; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2013-09-30       Impact factor: 5.958

7.  Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience.

Authors:  Andrey Germanovich Kriger; Stanislav Valer'evich Berelavichus; Ayrat Radikovich Kaldarov; Vladimir Igorevich Panteleev; David Semjonovich Gorin; Rimma Sangaevna Dugarova; Marina Yur'evna Yukina
Journal:  Gastrointest Tumors       Date:  2019-08-13

8.  Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma).

Authors:  Gian Paolo Fadini; Alberto Maran; Anna Valerio; Francesco Meduri; Mariarosa Pelizzo; Diego Miotto; Cristiano Lanza; Giuseppe Altavilla; Angelo Avogaro
Journal:  Case Rep Med       Date:  2011-07-03

9.  Generation and characterization of human insulin-releasing cell lines.

Authors:  Leticia Labriola; Maria G Peters; Karin Krogh; Iván Stigliano; Letícia F Terra; Cecilia Buchanan; Marcel C C Machado; Elisa Bal de Kier Joffé; Lydia Puricelli; Mari C Sogayar
Journal:  BMC Cell Biol       Date:  2009-06-19       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.